CONMED Corp - Common Stock (CNMD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CNMD on NYSE
CUSIP
207410101
Type / Class
Equity / Common Stock
Shares outstanding
30.9M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
35M
Holdings value
$1.82B
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
273
Number of buys
136
Number of sells
-140
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CONMED Corp - Common Stock (CNMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.1% $267M 4.68M BlackRock, Inc. Jun 30, 2025
FULLER & THALER ASSET MANAGEMENT, INC. 5.63% $92.4M 1.74M Fuller & Thaler Asset Management, Inc. Jun 30, 2025

Institutional Holders of CONMED Corp - Common Stock (CNMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 73.9K $3.47M +$210K $47.03 8
2025 Q2 35M $1.82B -$41.8M $52.08 273
2025 Q1 35.6M $2.15B -$20.5M $60.39 277
2024 Q4 35.8M $2.45B +$128M $68.44 277
2024 Q3 33.8M $2.43B -$126M $71.92 286
2024 Q2 35.7M $2.47B +$22.2M $69.32 291
2024 Q1 35.2M $2.82B -$99.5M $80.08 290
2023 Q4 525K $57.4M -$220K $109.51 3
2023 Q3 35.3M $3.56B -$9.47M $100.85 266
2023 Q2 35M $4.75B -$136M $135.89 256
2023 Q1 35.9M $3.73B +$69.7M $103.86 227
2022 Q4 35.4M $3.14B +$84.9M $88.64 234
2022 Q3 34.1M $2.73B +$59.7M $80.17 232
2022 Q2 33.4M $3.2B +$130M $95.76 265
2022 Q1 31.2M $4.64B +$60.2M $148.55 262
2021 Q4 31.7M $4.5B +$84.4M $141.76 255
2021 Q3 31.5M $4.13B +$16M $130.83 257
2021 Q2 31.4M $4.32B +$62.6M $137.43 248
2021 Q1 30.7M $4.01B +$77.3M $130.59 235
2020 Q4 30.5M $3.42B +$81.3M $112.00 239
2020 Q3 30.3M $2.38B +$64.7M $78.67 231
2020 Q2 29.5M $2.12B +$45.1M $71.99 219
2020 Q1 29M $1.66B -$52.4M $57.27 212
2019 Q4 29M $3.25B +$3.95M $111.83 260
2019 Q3 28.9M $2.78B -$21.9M $96.15 228
2019 Q2 29.2M $2.5B +$85.3M $85.57 221
2019 Q1 29.1M $2.42B +$177M $83.18 217
2018 Q4 27.1M $1.74B -$30.5M $64.20 201
2018 Q3 27.5M $2.18B -$3.78M $79.22 203
2018 Q2 27.6M $2.02B +$61.8M $73.20 191
2018 Q1 27.3M $1.73B -$35.4M $63.33 171
2017 Q4 27.8M $1.42B -$10.6M $50.97 153
2017 Q3 28M $1.47B +$16.9M $52.47 142
2017 Q2 27.3M $1.39B -$6.32M $50.94 146
2017 Q1 27.6M $1.23B +$136M $44.41 140
2016 Q4 27.6M $1.22B -$13.9M $44.17 144
2016 Q3 27.9M $1.12B -$5.79M $40.06 143
2016 Q2 27.8M $1.33B +$35.7M $47.73 149
2016 Q1 27.6M $1.16B +$75M $41.94 156
2015 Q4 27.4M $1.2B +$1.11M $44.05 149
2015 Q3 27.1M $1.29B -$18M $47.74 153
2015 Q2 26.3M $1.53B +$53.7M $58.27 153
2015 Q1 26.4M $1.33B +$40.8M $50.49 143
2014 Q4 25.9M $1.16B +$24.4M $44.96 154
2014 Q3 23.8M $876M +$6.14M $36.84 160
2014 Q2 23.6M $1.04B -$35.2M $44.15 178
2014 Q1 24.4M $1.06B -$30M $43.45 170